- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03272945
Linked-color Imaging for the Detection of Colorectal Flat Lesions
January 6, 2019 updated by: Akira Horiuchi, Showa Inan General Hospital
Linked-color Imaging Versus White Light for the Detection of Colorectal Flat Lesions: a Randomized, Controlled Trial
Linked color imaging (LCI) was recently developed and uses a laser endoscopic system (Fujifilm Co, Tokyo, Japan) that acquires images by simultaneously using narrow-band short-wavelength light and white-light (WL) in an appropriate balance.
LCI is a new image-enhancing technology that is intended to enhance slight color differences in the red region of the mucosa.
The acquired color information is reallocated to differentiate colors that are similar to the mucosal color, resulting in improved performance in depicting blood vessels, and additional image processing that enhances color separation for red color permits clear visualization of red blood vessels and white pits.
This modality may increase the detection rate of colorectal polyps by enhancing the visibility of colonic mucosal vessels.
In addition, it has been reported that LCI increases the visibility of colorectal flat lesions and contributes to improvement of the detection rate for these lesions.
The primary aim of the current study was to compare the detection rate of colorectal flat lesions of LCI cap-assisted colonoscopy with WL cap-assisted colonoscopy in prospective randomized trial.
In addition, we prospectively compared LCI and WL with regard to the visibility of colorectal flat lesions found in this study.
Study Overview
Study Type
Interventional
Enrollment (Actual)
400
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Nagano
-
Komagane, Nagano, Japan, 399-4191
- Showa Inan General Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
46 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- We enrolled consecutive patients who were referred for colonoscopy to our hospital for diagnostic work up of colonic symptoms, surveillance of colorectal polyps, and colorectal cancer screening.
Exclusion Criteria:
- familial colorectal cancer syndrome including familial adenomatous polyposis and hereditary non-polyposis colorectal cancer syndrome, personal history of colorectal cancer or inflammatory bowel disease and those who had previous colonic resection.
Patients who were considered to be unsafe for polypectomy, including patients with bleeding tendency and those with severe comorbid illnesses, were excluded. Those in whom <90% of mucosa was seen due to mixture of semisolid and solid colonic contents were also excluded because of poor bowel preparation.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: LCI
Once the randomization assignment was announced, the whole colonoscopy from insertion to cecum to withdrawal of endoscope was carried out entirely by using Linked-color imaging (LCI).
|
Linked-color imaging colonoscopy
|
|
Placebo Comparator: WL
Once the randomization assignment was announced, the whole colonoscopy from insertion to cecum to withdrawal of endoscope was carried out entirely by using white light (WL).
|
Linked-color imaging colonoscopy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Average prevalence of flat lesion /patient detected
Time Frame: procedure
|
The total number of flat colorectal lesion/patient was defined.
The average prevalence of flat lesion /patient detected was calculated.
|
procedure
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Adenoma detection rate
Time Frame: procedure
|
Adenoma detection rate was defined as the proportion of patients with at least one adenoma found on colonoscopy.
|
procedure
|
|
Polyp detection rate
Time Frame: procedure
|
Polyp detection rate was defined as the proportion of patients with at least one polyp found on colonoscopy.
|
procedure
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The visibility of colorectal flat lesions
Time Frame: 1 day
|
Six endoscopists interpreted the images of CLI and WL.
By using a previously reported visibility scale, we scored the visibility level on a scale of 1 to 4 and compared the two groups.
|
1 day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Akira Horiuchi, MD, Showa Inan General Hospital
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 6, 2017
Primary Completion (Actual)
December 31, 2018
Study Completion (Actual)
December 31, 2018
Study Registration Dates
First Submitted
September 2, 2017
First Submitted That Met QC Criteria
September 5, 2017
First Posted (Actual)
September 6, 2017
Study Record Updates
Last Update Posted (Actual)
January 8, 2019
Last Update Submitted That Met QC Criteria
January 6, 2019
Last Verified
January 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- LCI
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Colonic Polyp
-
University of ManitobaCompletedPolyps | Colonic Polyp | Polyp of Colon | Colo-rectal Cancer | Colon Polyp | Rectal Polyp | Polyp RectalCanada
-
South Tyneside and Sunderland NHS Foundation TrustMedtronic; Newcastle University; North Wales Organisation for Randomised Trials...CompletedColonic Polyp | Colorectal Adenoma | Colorectal Polyp | Colorectal SSA | Colorectal Adenomatous Polyp | Sessile Serrated Adenoma | Sessile Colonic PolypUnited Kingdom
-
White River Junction Veterans Affairs Medical CenterRecruitingRecurrence | Colonic Polyp | Colonoscopy | Complication | Duodenal PolypUnited States
-
Wulumuqi General Hospital of Lanzhou Military CommandAir Force Military Medical University, ChinaCompletedColonic Polyp | Intestinal PolypChina
-
King's College Hospital NHS TrustRecruitingPolyp of Colon | Colorectal PolypUnited Kingdom
-
Unity Health TorontoRecruiting
-
The University of Texas Health Science Center,...Withdrawn
-
Wuerzburg University HospitalCompleted
-
Valduce HospitalCompleted
-
Parc de Salut MarUnknown
Clinical Trials on Linked-color imaging
-
Changi General HospitalSingapore General HospitalCompletedEarly Gastric Cancer | Barrett EsophagusSingapore
-
Affiliated Hospital to Academy of Military Medical...UnknownUlcerative ColitisChina
-
Hospital Clinic of BarcelonaEuropean Society of Gastrointestinal EndoscopyCompleted
-
Affiliated Hospital to Academy of Military Medical...Shanghai 10th People's Hospital; Sixth Affiliated Hospital, Sun Yat-sen University and other collaboratorsCompletedGastritis | Atrophic Gastritis | Helicobacter Pylori Associated GastritisChina
-
Valduce HospitalCompleted
-
Valduce HospitalUnknown
-
Affiliated Hospital to Academy of Military Medical...Unknown
-
Shandong UniversityRecruitingColorectal Neoplasms | Colonic Polyps | Adenomatous Polyps | Adenoma Detection Rate | ChromoendoscopyChina
-
Fourth People's Hospital of ShenyangCompleted
-
Dr. Shawkat MichelCompletedLife Threatening Diseases | Embolic ShowerCanada